FDA — authorised 21 August 2009
- Application: NDA020427
- Marketing authorisation holder: LUNDBECK PHARMS LLC
- Local brand name: SABRIL
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Vigabatrin Tablets in United States
FDA authorised Vigabatrin Tablets on 21 August 2009
Marketing authorisation
Frequently asked questions
Is Vigabatrin Tablets approved in United States?
Yes. FDA authorised it on 21 August 2009.
Who is the marketing authorisation holder for Vigabatrin Tablets in United States?
LUNDBECK PHARMS LLC holds the US marketing authorisation.